SURGIFLO Hemostatic Matrix Kit w/Thrombin
FDA premarket approval P990004/S033 · decided 2019-02-20
Approval details
- PMA number
- P990004
- Supplement
- S033
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- SURGIFLO Hemostatic Matrix Kit w/Thrombin
- Generic name
- Agent, absorbable hemostatic, collagen based
- Applicant
- Ferrosan Meidcal Devices A/S
- Date received
- 2018-09-05
- Decision date
- 2019-02-20
- Days to decision
- 168 days
- Decision code
- APPR
- Product code
- LMF
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Soeborg
- Statement
- Approval for a change to the pallet configuration for the Ethylene Oxide sterilization of the Thrombin Kit Package which is a part of the SURGIFLO Hemostatic Matrix Kit with Thrombin.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.